See how a treatment for SMA works
The following article is content provided by our sponsor Novartis Gene Therapies, Inc. The views and opinions expressed in the content below are not the views and opinions of HCP SMA News Today or its parent company, BioNews Inc. ZOLGENSMA® (onasemnogene abeparvovec-xioi) is a gene therapy for the treatment…